Use access key #2 to skip to page content.
$1.51 0.26 (20.80%)
10/10/2008 4:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
**

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar MCvest (< 20) Submitted: 7/12/07 9:04 PM : Outperform Start Price: $13.50 ACAD Score: -46.07

ACAD (VERY speculative, very up and down stock but I am betting on drug phase approval sending this stock up 100%)

Report this Post Replies: 0 | Reply

Featured Broker Partners